Have a personal or library account? Click to login
Central retesting of breast cancer with HER2 immunohistochemistry score of 0 or 1+ using silver-enhanced in situ hybridisation: a multicentre, prospective study in Greece Cover

Central retesting of breast cancer with HER2 immunohistochemistry score of 0 or 1+ using silver-enhanced in situ hybridisation: a multicentre, prospective study in Greece

Forum of Clinical Oncology
Volume 5 (2014): Issue 1 (July 2014)
By: Savvas Papadopoulos,  Petroula Arapantoni-Dadioti,  Konstantinos Sfikas,  Artemis Stylianidou,  Helen Trichia,  Eleftheria Katsamagou,  Vaia Baleki and  Johannes Noe  
Open Access
|Aug 2014

Metrics

DOI: https://doi.org/10.2478/fco-2014-0004 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 20 - 28
Published on: Aug 14, 2014
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Breast cancer,
HER2,
Immunohistochemistry,
Silver in situ hybridisation
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2014 Savvas Papadopoulos, Petroula Arapantoni-Dadioti, Konstantinos Sfikas, Artemis Stylianidou, Helen Trichia, Eleftheria Katsamagou, Vaia Baleki, Johannes Noe, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 5 (2014): Issue 1 (July 2014)Next article